Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment

Epilepsia

Volumn 43, Issue 4, 2002, Pages 394-398

  Sackellares, J Chris ^a,d   Krauss, Gregory ^b   Sommerville, Kenneth W ^c   Deaton, Roger ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c ABBOTT LABORATORIES   (United States)

^d Department of Neuroscience ^*  (United States)

Author keywords

Adverse effects; Anticonvulsants; Psychotic disorders; Tiagabine; Vigabatrin

Indexed keywords

PHENYTOIN; PLACEBO; TIAGABINE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; GABA AGONISTS; HALLUCINATIONS; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTICENTER STUDIES; NIPECOTIC ACIDS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036218394     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.16000.x     Document Type: Article

References (26)

1. Neuropsychiatric consequences of pharmacotherapy
2. Anticonvulsants and psychopathology
3. Schizophrenia-like psychosis associated with anti-convulsant toxicity
4. Psychiatric implications of anticonvulsant drugs
5. Phenytoin chronic toxicity and associated psychosis
6. Organic mania induced by phenytoin: A case report
7. Psychosis from valproate intoxication
8. Anticonvulsant-induced psychiatric disorders
9. Psychopathology in epilepsy: Prevalence, phenomenology and management
10. Psychiatric disorders and epilepsy
11. Summary and conclusions
12. Psychotic syndromes in epilepsy
13. Acute psychological disorders in patients with epilepsy: A nation-wide study
14. Vigabatrin and psychosis
15. Mechanisms of action of new antiepileptic drugs
16. A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor
17. Tiagabine therapy for complex partial seizures
18. Tiagabine for complex partial seizures: A randomized, add-on, dose-response trial
19. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures
20. Serial EEG investigations during psychotic episodes in epileptic patients and during schizophrenic attacks
21. Post-ictal psychosis
22. Psychosis and temporal lobe epilepsy
23. Postictal and chronic psychosis in patients with temporal lobe epilepsy
24. Statistical study of clinical and electroencephalographic manifestations of 536 psychotic episodes occurring in 516 epilepsies between clinical seizures
25. Postictal psychosis after partial complex seizures: A multiple case study